About this trial
This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
Eligibility criteria
Qualifiers
Age ≥18 years, both male and female.
Pathologically confirmed diagnosis of gastrointestinal cancer (gastric cancer or colorectal Cancer).
Detailed medical records available prior to treatment (including chief complaint, history of present illness, radiological examinations, pathological examinations, laboratory tests, etc.).
Participants will receive complete treatment in the participating hospitals.
Disqualifiers
Participants with cancers other than gastrointestinal cancers.
Participants who receive treatment in multiple hospitals.
Trial design
Treatments tested in this trial
- Clinician-Directed Treatment Plan
- ChatGPT-Assisted Treatment Plan
Treatment groups
Sponsors and collaborators
Chinese Academy of Sciences
Lead sponsor
ZhuHai Hospital
Collaborator
Fifth Affiliated Hospital, Sun Yat-Sen University
Collaborator
Jiangmen Central Hospital
Collaborator
Peking University Cancer Hospital (Inner Mongolia Campus)
Collaborator
San Raffaele University Hospital, Italy
Collaborator
University Hospital Magdeburg, Germany
Collaborator
City of Hope Medical Center
Collaborator